In a 13-year-old boy presenting with fatigue, recurrent vomiting, headache, and dizziness, what is the most likely cause of the posterior‑fossa lesions seen on CT scans?

Most Likely Diagnosis: Medulloblastoma

In a 13-year-old boy presenting with fatigue, recurrent vomiting, headache, and dizziness with posterior fossa lesions on CT, the most likely diagnosis is medulloblastoma, which accounts for the majority of posterior fossa tumors in this age group and characteristically presents with these exact symptoms due to increased intracranial pressure and cerebellar involvement.

Clinical Reasoning

The clinical presentation is classic for a posterior fossa mass:

• Age: 13 years falls within the peak incidence for posterior fossa tumors (first decade of life) 1
• Symptoms: The triad of headache, vomiting, and dizziness represents raised intracranial pressure, which is the most common presenting symptom pattern for posterior fossa tumors 1
• Location: Posterior fossa tumors are the leading cause of death from solid tumors in childhood 2

Differential Diagnosis by Frequency

Based on current NCCN guidelines and supporting research, the most common posterior fossa tumors in children are 3, 2:

1. Medulloblastoma (most common)

   • Appears as a large, heterogeneous posterior fossa mass
   • Typically occupies the fourth ventricle or cerebellar hemisphere
   • Shows reduced diffusion due to high cellularity on imaging
   • Heterogeneous cyst formation or necrosis with varying enhancement 3
   • Mean size at diagnosis approximately 45.6 mm 4

2. Cerebellar Astrocytoma (second most common)

   • More commonly located in cerebellar hemispheres
   • Different imaging characteristics than medulloblastoma

3. Ependymoma (third most common)

   • Often arises from fourth ventricle floor
   • Distinct imaging features

4. Atypical Teratoid/Rhabdoid Tumor

   • More aggressive presentation
   • Typically younger age group

Critical Next Steps

Immediate imaging requirements 3:

• MRI brain with and without contrast (superior to CT for characterization)
• Spine MRI with contrast (to evaluate for leptomeningeal dissemination, which is more evident on MRI than CT) 3
• Obtain sagittal T2-weighted and postcontrast sagittal/axial T1-weighted images of entire spine
• Consider DWI sequences to assess cellularity and predict molecular subtypes 3

Surgical planning 3:

• Goal is maximal safe resection while minimizing neurologic deficits
• Obtain adequate tissue for both histopathologic diagnosis AND molecular genetic characterization
• Molecular findings are critical for risk stratification and treatment planning 3

Important Caveats

Do not assume all posterior fossa masses are malignant. The differential also includes 1, 5:

• Congenital anomalies (18.6% of cases) - arachnoid cysts most common
• Vascular lesions
• Atrophy/hypoplasia
• Rare entities like mature teratomas (if hyperdense with calcifications and fat) 6

Cerebellar hemisphere location (39.5% of posterior fossa lesions) is most common, followed by fourth ventricle involvement 5.

Hydrocephalus management: If present, cerebrospinal fluid diversion via ventriculoperitoneal shunt or endoscopic third ventriculostomy is acceptable 3.

Risk Stratification Considerations

Once diagnosis is confirmed, molecular subtyping is essential 3:

• WNT subtype: Best prognosis (>95% survival), may show intratumoral hemorrhage
• SHH subtype: Intermediate prognosis
• Group 3: Poor prognosis (20-30% 5-year survival), especially with MYC amplification
• Group 4: Better prognosis (75-90% survival)

Treatment depends on risk stratification based on molecular findings, extent of resection, presence of metastases (M stage), and histology (classic vs. large cell/anaplastic) 3.